Compare DexCom, Inc. (DXCM) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs United Parcel Service Inc — how do they compare? DexCom, Inc. trades at $77.6 (market cap $28.06B), while United Parcel Service Inc trades at $116.39 (market cap $96.00B). The key difference: United Parcel Service Inc is far larger — about 3.4× DexCom, Inc.'s market cap, and United Parcel Service Inc pays a 5.81% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | UPS | |
|---|---|---|
Market Cap | $28.06B | $96.00B |
Sector | Health | Industrials |
52-Week High | $89.53 | $120.00 |
52-Week Low | $54.84 | $82.58 |
Enterprise Value | $27.03B | $118.86B |
Volume | — | 2,288,643 |
Dividend Yield | — | 5.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
UPS trades at $116.30, up 2.31% recently, with a bullish technical signal and strong profitability metrics including a 33.41% ROE. Recent earnings beats and a $48 million healthcare logistics investment highlight operational strength, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. The stock is near resistance at $117, with a consensus price target of $112 below the current price.
The outlook is mixed: cost efficiency and dividend payments support value, but competitive pressures from Amazon and muted revenue growth pose risks. Analysts are divided, with 42% bullish and 49% neutral, suggesting cautious optimism amid headwinds. The Q2 2026 earnings report on July 28, 2026, will be critical for direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
